We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IVDA:NASDAQIveda Solutions, Inc. Analysis

Data as of 2026-06-14 - not real-time

$0.28

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Iveda Solutions trades at roughly $0.28, giving it a market capitalization of just over $3 million – a strikingly low valuation relative to its $5.3 million revenue base. Revenue has slumped 64% year‑over‑year and the company is operating at a -60% profit margin, with operating cash flow and free cash flow both deeply negative. Despite a cash pile of $5.15 million, the balance sheet is strained by a debt‑to‑equity ratio near 15 and a negative ROE of almost -88%, indicating limited financial flexibility. Technical indicators reinforce the downside narrative: the price sits below the 20‑day (0.324) and 50‑day (0.305) SMAs, the MACD is bearish, and RSI hovers at 40, suggesting modest weakness. Volatility is extreme at >108% over the past month, beta exceeds 2.5 in the computed data, and the stock is hovering near its $0.27 support level with $0.42 resistance.
The forward outlook shows a modestly positive EPS estimate of $1.84, translating to a forward P/E of 0.15 and a price‑to‑book of 0.35, which would appear dramatically cheap if the company could reverse its cash burn. However, the absence of any dividend, a high max drawdown of nearly 90%, and a sector (Security & Protection Services) that faces tightening regulatory scrutiny temper optimism. Given the extreme market sentiment of “Extreme Greed” but the underlying fundamentals, the stock presents a high‑risk, value‑oriented play rather than a growth opportunity.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Price below all major moving averages and bearish MACD
  • Severe revenue decline and negative operating margins
  • Extreme short‑term volatility and proximity to support level

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward EPS estimate suggests potential upside if turnaround succeeds
  • Cash reserves may sustain operations through short‑term restructuring
  • High debt‑to‑equity and ongoing cash burn limit confidence

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Large addressable market for AI‑driven surveillance and IoT solutions
  • Execution risk remains high given historic losses and regulatory exposure
  • Valuation remains deeply discounted relative to book and sales metrics

Key Metrics & Analysis

Financial Health

Revenue Growth-64.10%
Profit Margin-60.57%
P/E Ratio0.2
ROE-87.80%
ROA-34.75%
Debt/Equity14.84
P/B Ratio0.3
Op. Cash Flow$-2027501
Free Cash Flow$-919520
Industry P/E30.6

Technical Analysis

TrendNeutral
RSI40.0
Support$0.27
Resistance$0.42
MA 20$0.32
MA 50$0.31
MA 200$0.78
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta2.61
Volatility108.03%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.